Dr. Sarah Diermeier
1.7K posts
@oncogenie
Developing the next generation of RNA medicines 🇩🇪🇳🇿
For #WomensHistoryMonth, we're celebrating outstanding scientists in the biotech industry. We salute Sarah Diermeier, founder and chief scientific officer of Amaroq Therapeutics, which is focused on developing a new class of therapeutics that target long non-coding RNAs in cancer
Our #NZSO2023 Precision Medicine session was excellent! Ngā mihi incredible speakers for your korero: @stephenqwong, @oncogenie, Dr Ben Lawrence, Dr Tracy Hale, & Dr Emma Nolan!
Elated to announce the success of our MBIE Programme, after many years of planning and some disappointments. Working towards further invigorating New Zealand’s medical device industry and co-development with Māori communities to help ease the burden of brain diseases.
The Government is seeking feedback on proposed changes to Aotearoa New Zealand’s legislation and regulations for genetically modified organisms (GMOs) used in laboratory settings and for biomedical therapies. For full details, visit consult.environment.govt.nz/comms/gmo-regu…
Diversity not essential for research excellence – Nobel pioneer Germany’s only female Nobel scientist questions notion that diversity is key component of research success in modern science, writes Jack Grove @jgro_the bit.ly/3JzXZaw
